{"id":2723,"date":"2018-03-15T12:15:44","date_gmt":"2018-03-15T06:45:44","guid":{"rendered":"https:\/\/uatblog.lalpathlabs.com\/blog\/?p=2723"},"modified":"2023-10-12T17:38:11","modified_gmt":"2023-10-12T12:08:11","slug":"csir-authorises-dr-lal-pathlabs-genetic-tests","status":"publish","type":"post","link":"https:\/\/www.lalpathlabs.com\/blog\/csir-authorises-dr-lal-pathlabs-genetic-tests\/","title":{"rendered":"CSIR Authorises Dr Lal PathLabs for Genetic Tests"},"content":{"rendered":"

Hoping to use private pathology labs to reach out to people, the\u00a0Council of Scientific and Industrial Research\u00a0(CSIR) on Thursday licensed a private lab for 27 genetic tests<\/a> it has developed over years.<\/p>\n

Officials said that the CSIR’s Institute of\u00a0Genomics\u00a0and Integrative\u00a0Biology\u00a0(CSIR-IGIB) has entered into partnership with Dr Lal PathLabs, a\u00a0private chain\u00a0of labs, and licensed it with technology.<\/p>\n

\n
These tests are expected to be launched over the period of one year.<\/div>\n<\/div>\n

Genetic diseases, though are individually rare, cumulatively affect a large number of individuals — an estimated 70 million Indians.<\/p>\n

It is anticipated that the wide network of\u00a0Dr Lal PathLabs\u00a0would enable easy access to the genetic tests to large number of patients across the country and potentially enable wide utility of genetic tests by clinicians,” said a statement from the CSIR.<\/p>\n

According to the CSIR, mostly an appropriate diagnosis is not arrived at due to lack of general awareness on genetic diseases, lack of access and high cost of\u00a0appropriate genetic diagnostic services.<\/p>\n

It is estimated that an average patient with\u00a0rare disease\u00a0has to go through multiple\u00a0healthcare visits\u00a0and\u00a0diagnostic tests\u00a0and takes approximately seven years to arrive at a precise diagnosis,” the CSIR said.<\/p>\n

Genomics, however, look at the individual case and figures out a personalise case for better treatment.<\/p>\n

It added that so far through the CSIR-IGIB’s previous efforts, over 14,000 genetic tests have been carried out, benefiting over 4,000 needy patients from across the country through a\u00a0clinical network\u00a0encompassing over 25 major medical centres spanning the length and breadth of the country.<\/p>\n

CSIR has a major focus on R&D pertaining to Affordable\u00a0Health\u00a0Care… The tests developed and licensed to\u00a0Dr Lal PathLabs\u00a0would provide a much needed support system to the doctors in diagnosing the identified genetic disorders,” said Dr Girish Sahni, Director General, CSIR.<\/p>\n

Ref Link<\/strong>\u00a0:-\u00a0http:\/\/www.business-standard.com\/article\/news-ians\/csir-authorises-private-path-lab-for-genetic-tests-118030900026_1.html<\/a><\/p>\n